Clinical Trial Update: A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating single-agent selinexor versus physician's choice in participants with previously treated myelofibrosis; the trial is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• XPOVIO (selinexor) (selinexor)

Snippet

Sponsor: Karyopharm Therapeutics Inc | Conditions: Myelofibrosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING